nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—NR3C1—glaucoma	0.785	1	CbGaD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.0118	0.164	CbGpPWpGaD
Amcinonide—Stinging—Dipivefrin—glaucoma	0.00908	0.068	CcSEcCtD
Amcinonide—Cataract subcapsular—Dorzolamide—glaucoma	0.00843	0.0631	CcSEcCtD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00804	0.112	CbGpPWpGaD
Amcinonide—Stinging—Echothiophate—glaucoma	0.00761	0.057	CcSEcCtD
Amcinonide—Hypertrichosis—Bimatoprost—glaucoma	0.00684	0.0513	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Brimonidine—glaucoma	0.00659	0.0494	CcSEcCtD
Amcinonide—Hypertrichosis—Travoprost—glaucoma	0.00576	0.0432	CcSEcCtD
Amcinonide—Stinging—Carbachol—glaucoma	0.00454	0.034	CcSEcCtD
Amcinonide—Stinging—Levobunolol—glaucoma	0.00447	0.0335	CcSEcCtD
Amcinonide—Tenderness—Carbachol—glaucoma	0.00421	0.0316	CcSEcCtD
Amcinonide—Stinging—Latanoprost—glaucoma	0.00414	0.031	CcSEcCtD
Amcinonide—Hypertrichosis—Betaxolol—glaucoma	0.0038	0.0285	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00329	0.0459	CbGpPWpGaD
Amcinonide—Stinging—Bimatoprost—glaucoma	0.00321	0.024	CcSEcCtD
Amcinonide—Stinging—Brimonidine—glaucoma	0.00284	0.0213	CcSEcCtD
Amcinonide—Stinging—Dorzolamide—glaucoma	0.00272	0.0203	CcSEcCtD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.00267	0.0373	CbGpPWpGaD
Amcinonide—Dermatitis contact—Apraclonidine—glaucoma	0.00265	0.0199	CcSEcCtD
Amcinonide—Rash pustular—Pilocarpine—glaucoma	0.00261	0.0195	CcSEcCtD
Amcinonide—Stinging—Pilocarpine—glaucoma	0.00257	0.0192	CcSEcCtD
Amcinonide—Tenderness—Travoprost—glaucoma	0.00251	0.0188	CcSEcCtD
Amcinonide—Dermatitis contact—Brimonidine—glaucoma	0.00228	0.0171	CcSEcCtD
Amcinonide—Pain—Dipivefrin—glaucoma	0.00224	0.0168	CcSEcCtD
Amcinonide—Dermatitis contact—Dorzolamide—glaucoma	0.00217	0.0163	CcSEcCtD
Amcinonide—Dermatitis contact—Travoprost—glaucoma	0.00216	0.0162	CcSEcCtD
Amcinonide—ANXA1—G alpha (q) signalling events—OPN4—glaucoma	0.00206	0.0288	CbGpPWpGaD
Amcinonide—Dermatitis contact—Pilocarpine—glaucoma	0.00205	0.0154	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—C1QB—glaucoma	0.00201	0.028	CbGpPWpGaD
Amcinonide—Pain—Echothiophate—glaucoma	0.00188	0.0141	CcSEcCtD
Amcinonide—ANXA1—G alpha (q) signalling events—PTGFR—glaucoma	0.00186	0.026	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00185	0.0258	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00166	0.0232	CbGpPWpGaD
Amcinonide—Dermatitis contact—Clonidine—glaucoma	0.00164	0.0123	CcSEcCtD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.00149	0.0208	CbGpPWpGaD
Amcinonide—Stinging—Timolol—glaucoma	0.00146	0.0109	CcSEcCtD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00137	0.0191	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	0.00135	0.0189	CbGpPWpGaD
Amcinonide—Fluocinonide—SMO—glaucoma	0.00132	0.135	CrCbGaD
Amcinonide—Infection—Carbachol—glaucoma	0.0013	0.00976	CcSEcCtD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00123	0.0172	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00122	0.017	CbGpPWpGaD
Amcinonide—Pain—Carbachol—glaucoma	0.00112	0.0084	CcSEcCtD
Amcinonide—Pain—Levobunolol—glaucoma	0.0011	0.00827	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—NGFR—glaucoma	0.00106	0.0148	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—OPN4—glaucoma	0.00104	0.0145	CbGpPWpGaD
Amcinonide—Pain—Latanoprost—glaucoma	0.00102	0.00767	CcSEcCtD
Amcinonide—Infection—Apraclonidine—glaucoma	0.000951	0.00712	CcSEcCtD
Amcinonide—Pruritus—Diclofenamide—glaucoma	0.00095	0.00712	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—PTGFR—glaucoma	0.000938	0.0131	CbGpPWpGaD
Amcinonide—Dermatitis—Metipranolol—glaucoma	0.000929	0.00696	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—BDNF—glaucoma	0.000925	0.0129	CbGpPWpGaD
Amcinonide—Infection—Bimatoprost—glaucoma	0.000922	0.00691	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000922	0.0129	CbGpPWpGaD
Amcinonide—Pruritus—Levobunolol—glaucoma	0.000913	0.00684	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—IL1A—glaucoma	0.000888	0.0124	CbGpPWpGaD
Amcinonide—Pruritus—Latanoprost—glaucoma	0.000847	0.00635	CcSEcCtD
Amcinonide—Dermatitis—Carbachol—glaucoma	0.000826	0.00619	CcSEcCtD
Amcinonide—Pain—Apraclonidine—glaucoma	0.000819	0.00613	CcSEcCtD
Amcinonide—Infection—Brimonidine—glaucoma	0.000816	0.00612	CcSEcCtD
Amcinonide—Pain—Bimatoprost—glaucoma	0.000794	0.00594	CcSEcCtD
Amcinonide—Dermatitis—Methazolamide—glaucoma	0.000779	0.00584	CcSEcCtD
Amcinonide—Infection—Travoprost—glaucoma	0.000776	0.00581	CcSEcCtD
Amcinonide—Infection—Brinzolamide—glaucoma	0.000767	0.00574	CcSEcCtD
Amcinonide—Dermatitis—Latanoprost—glaucoma	0.000754	0.00565	CcSEcCtD
Amcinonide—Infection—Pilocarpine—glaucoma	0.000737	0.00552	CcSEcCtD
Amcinonide—Pain—Brimonidine—glaucoma	0.000703	0.00526	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000687	0.0096	CbGpPWpGaD
Amcinonide—Pruritus—Apraclonidine—glaucoma	0.000677	0.00507	CcSEcCtD
Amcinonide—Pain—Dorzolamide—glaucoma	0.000671	0.00503	CcSEcCtD
Amcinonide—Pain—Travoprost—glaucoma	0.000668	0.00501	CcSEcCtD
Amcinonide—Pain—Brinzolamide—glaucoma	0.00066	0.00494	CcSEcCtD
Amcinonide—Pruritus—Bimatoprost—glaucoma	0.000657	0.00492	CcSEcCtD
Amcinonide—Pain—Pilocarpine—glaucoma	0.000634	0.00475	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000633	0.00884	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000629	0.00879	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—EDN1—glaucoma	0.000618	0.00863	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000616	0.00861	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—EDN1—glaucoma	0.00061	0.00852	CbGpPWpGaD
Amcinonide—Dermatitis—Apraclonidine—glaucoma	0.000603	0.00452	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—OPN4—glaucoma	0.000588	0.00822	CbGpPWpGaD
Amcinonide—Infection—Clonidine—glaucoma	0.000588	0.00441	CcSEcCtD
Amcinonide—Dermatitis—Bimatoprost—glaucoma	0.000585	0.00438	CcSEcCtD
Amcinonide—Pruritus—Brimonidine—glaucoma	0.000581	0.00435	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000556	0.00776	CbGpPWpGaD
Amcinonide—Pruritus—Dorzolamide—glaucoma	0.000555	0.00416	CcSEcCtD
Amcinonide—Pruritus—Travoprost—glaucoma	0.000553	0.00414	CcSEcCtD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000553	0.00772	CbGpPWpGaD
Amcinonide—Pruritus—Brinzolamide—glaucoma	0.000546	0.00409	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000538	0.00752	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—OPN4—glaucoma	0.000534	0.00746	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—C3—glaucoma	0.000533	0.00744	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PTGFR—glaucoma	0.00053	0.0074	CbGpPWpGaD
Amcinonide—Pruritus—Pilocarpine—glaucoma	0.000525	0.00393	CcSEcCtD
Amcinonide—Dermatitis—Brimonidine—glaucoma	0.000518	0.00388	CcSEcCtD
Amcinonide—Infection—Betaxolol—glaucoma	0.000512	0.00384	CcSEcCtD
Amcinonide—Pain—Clonidine—glaucoma	0.000506	0.00379	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—PTGS2—glaucoma	0.000498	0.00695	CbGpPWpGaD
Amcinonide—Dermatitis—Dorzolamide—glaucoma	0.000494	0.0037	CcSEcCtD
Amcinonide—Dermatitis—Travoprost—glaucoma	0.000492	0.00369	CcSEcCtD
Amcinonide—Dermatitis—Brinzolamide—glaucoma	0.000486	0.00364	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—PTGFR—glaucoma	0.000481	0.00672	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—SMO—glaucoma	0.000473	0.0066	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CDKN1B—glaucoma	0.000471	0.00658	CbGpPWpGaD
Amcinonide—Dermatitis—Pilocarpine—glaucoma	0.000467	0.0035	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000461	0.00643	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LRP12—glaucoma	0.000455	0.00636	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—C3—glaucoma	0.00045	0.00628	CbGpPWpGaD
Amcinonide—Pain—Betaxolol—glaucoma	0.000441	0.0033	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000438	0.00611	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MMP9—glaucoma	0.000437	0.0061	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—EDN1—glaucoma	0.000429	0.00599	CbGpPWpGaD
Amcinonide—Difluprednate—NR3C1—glaucoma	0.000425	0.0435	CrCbGaD
Amcinonide—Pruritus—Clonidine—glaucoma	0.000419	0.00314	CcSEcCtD
Amcinonide—Infection—Timolol—glaucoma	0.000418	0.00313	CcSEcCtD
Amcinonide—Prednicarbate—NR3C1—glaucoma	0.000412	0.0421	CrCbGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000409	0.00572	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—glaucoma	0.000407	0.00568	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000398	0.00555	CbGpPWpGaD
Amcinonide—Diflorasone—NR3C1—glaucoma	0.00039	0.0399	CrCbGaD
Amcinonide—Desonide—NR3C1—glaucoma	0.00039	0.0399	CrCbGaD
Amcinonide—Desoximetasone—NR3C1—glaucoma	0.00038	0.0389	CrCbGaD
Amcinonide—Loteprednol—NR3C1—glaucoma	0.000375	0.0384	CrCbGaD
Amcinonide—Dermatitis—Clonidine—glaucoma	0.000373	0.00279	CcSEcCtD
Amcinonide—Pruritus—Betaxolol—glaucoma	0.000365	0.00273	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP1—glaucoma	0.00036	0.00503	CbGpPWpGaD
Amcinonide—Pain—Timolol—glaucoma	0.00036	0.0027	CcSEcCtD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000358	0.00499	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000339	0.00473	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—glaucoma	0.000336	0.00469	CbGpPWpGaD
Amcinonide—Flurandrenolide—NR3C1—glaucoma	0.000333	0.0341	CrCbGaD
Amcinonide—Flumethasone Pivalate—NR3C1—glaucoma	0.000327	0.0335	CrCbGaD
Amcinonide—Dermatitis—Betaxolol—glaucoma	0.000325	0.00243	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000322	0.00449	CbGpPWpGaD
Amcinonide—Halobetasol Propionate—NR3C1—glaucoma	0.000322	0.0329	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000321	0.00448	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	0.000317	0.00443	CbGpPWpGaD
Amcinonide—Cortisone acetate—NR3C1—glaucoma	0.000317	0.0324	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—OPN4—glaucoma	0.000316	0.00441	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000313	0.00437	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—EDN1—glaucoma	0.000312	0.00435	CbGpPWpGaD
Amcinonide—Budesonide—NR3C1—glaucoma	0.000299	0.0306	CrCbGaD
Amcinonide—Pruritus—Timolol—glaucoma	0.000298	0.00223	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—glaucoma	0.000296	0.00414	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HEYL—glaucoma	0.000293	0.0041	CbGpPWpGaD
Amcinonide—Fluticasone furoate—NR3C1—glaucoma	0.000293	0.03	CrCbGaD
Amcinonide—Mometasone—NR3C1—glaucoma	0.000285	0.0291	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—PTGFR—glaucoma	0.000284	0.00397	CbGpPWpGaD
Amcinonide—Rimexolone—NR3C1—glaucoma	0.000281	0.0288	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—C3—glaucoma	0.000272	0.0038	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000267	0.00372	CbGpPWpGaD
Amcinonide—Dermatitis—Timolol—glaucoma	0.000265	0.00199	CcSEcCtD
Amcinonide—Fluocinonide—NR3C1—glaucoma	0.000265	0.0272	CrCbGaD
Amcinonide—Beclomethasone—NR3C1—glaucoma	0.000265	0.0272	CrCbGaD
Amcinonide—Fluocinolone Acetonide—NR3C1—glaucoma	0.000258	0.0264	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN2A—glaucoma	0.000255	0.00357	CbGpPWpGaD
Amcinonide—Clobetasol propionate—NR3C1—glaucoma	0.000251	0.0257	CrCbGaD
Amcinonide—Flunisolide—NR3C1—glaucoma	0.000251	0.0257	CrCbGaD
Amcinonide—Fludrocortisone—NR3C1—glaucoma	0.000251	0.0257	CrCbGaD
Amcinonide—Ciclesonide—NR3C1—glaucoma	0.000244	0.025	CrCbGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000243	0.0034	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—SMO—glaucoma	0.000243	0.00339	CbGpPWpGaD
Amcinonide—Fluorometholone—NR3C1—glaucoma	0.000242	0.0248	CrCbGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000234	0.00326	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—FAS—glaucoma	0.000231	0.00323	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000229	0.00319	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000226	0.00316	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000224	0.00313	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RPTOR—glaucoma	0.000222	0.00311	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NCK2—glaucoma	0.000215	0.00301	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	0.00021	0.00293	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	0.000207	0.0029	CbGpPWpGaD
Amcinonide—Fluoxymesterone—NR3C1—glaucoma	0.000207	0.0212	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000202	0.00281	CbGpPWpGaD
Amcinonide—Triamcinolone—NR3C1—glaucoma	0.000197	0.0202	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—HDAC9—glaucoma	0.000183	0.00256	CbGpPWpGaD
Amcinonide—Prednisone—NR3C1—glaucoma	0.000179	0.0183	CrCbGaD
Amcinonide—Fluticasone Propionate—NR3C1—glaucoma	0.000176	0.018	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—EDN1—glaucoma	0.000176	0.00246	CbGpPWpGaD
Amcinonide—Prednisolone—NR3C1—glaucoma	0.000165	0.0169	CrCbGaD
Amcinonide—Betamethasone—NR3C1—glaucoma	0.000162	0.0165	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—EDN1—glaucoma	0.00016	0.00223	CbGpPWpGaD
Amcinonide—Dexamethasone—CYP1B1—glaucoma	0.000158	0.0162	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—C3—glaucoma	0.000154	0.00215	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SMO—glaucoma	0.000143	0.002	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—glaucoma	0.000142	0.00199	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—C3—glaucoma	0.00014	0.00195	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NTRK2—glaucoma	0.000131	0.00183	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	0.000125	0.00175	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NGFR—glaucoma	0.000112	0.00157	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—glaucoma	0.000112	0.0115	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—NTRK1—glaucoma	0.000107	0.00149	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	9.94e-05	0.00139	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	9.91e-05	0.00138	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN2B—glaucoma	9.85e-05	0.00138	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—glaucoma	9.83e-05	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EDN1—glaucoma	9.45e-05	0.00132	CbGpPWpGaD
Amcinonide—Dexamethasone—NR3C1—glaucoma	9.4e-05	0.00962	CrCbGaD
Amcinonide—Betamethasone—PTGS2—glaucoma	9.17e-05	0.00939	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—NGF—glaucoma	8.68e-05	0.00121	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	8.49e-05	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—C3—glaucoma	8.25e-05	0.00115	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—glaucoma	7.68e-05	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CAV1—glaucoma	7.61e-05	0.00106	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FN1—glaucoma	7.25e-05	0.00101	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BAD—glaucoma	7.16e-05	0.001	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOS3—glaucoma	5.76e-05	0.000804	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—glaucoma	5.33e-05	0.00546	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1B—glaucoma	4.99e-05	0.000696	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CDKN2B—glaucoma	4.79e-05	0.000668	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—glaucoma	4.62e-05	0.000645	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—glaucoma	4.15e-05	0.000579	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—glaucoma	3.13e-05	0.000438	CbGpPWpGaD
